Search filters

List of works by Ross W. Stephens

A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation.

scientific article

A radioassay for proteolytic cleavage of isolated cartilage proteoglycan. I. Separation principles and variables

scientific article published on 01 October 1978

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

scientific article

Binding of tissue-type plasminogen activator to human melanoma cells

scientific article

Calf thymus GMP reductase: control by XMP.

scientific article

Cationised radiolabelled nanoparticles for perfusion imaging of the lungs

scientific article published on 4 December 2012

Characterisation of cell-surface procoagulant activities using a microcarrier model

scientific article published on December 1996

Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor

scientific article

Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures

scientific article published on December 1988

Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.

scientific article published on September 1993

Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor

scientific article published on 01 July 1989

Effects of the Schirmer test on the fibrinolytic system in the tear fluid

scientific article published on 01 February 1990

Enhanced activation of prourokinase by human RC2A leukemia cells

scientific article published on July 1991

Functional overlap between two classes of matrix-degrading proteases in wound healing

scientific article published on September 1999

Heparin binding to the urokinase kringle domain

scientific article published on August 1992

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

scientific article published in January 2002

Human serum and synovial fluid hyaluronidase--bovine testicular hyaluronidase is not a valid substitute in drug evaluation studies

scientific article published on July 1976

Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat

scientific article published in August 2001

Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit

scientific article published on 01 September 1996

Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue-type plasminogen activator

scientific article published on 01 July 1989

Inhibition of synovial fluid lysosomal glycosidases by anti-arthritic gold preparations

scientific article published on 01 April 1978

Loss of ELISA specificity due to biotinylation of monoclonal antibodies

scientific article published on 01 February 2000

Marker of erosive progression in RA.

scientific article published in August 2000

Microplate immunocapture assay for plasminogen activators and their specific inhibitors

scientific article published on 01 December 1987

Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators

scientific article published on 01 November 1983

Monoclonal antibodies inhibitory to human plasmin. Definitive demonstration of a role for plasmin in activating the proenzyme of urokinase-type plasminogen activator

scientific article published in August 1986

Neutral protease inhibitors from human intervertebral disc and femoral head articular cartilage

scientific article

Novel properties of human monocyte plasminogen activator.

scientific article

Persistence of plasmin-mediated pro-urokinase activation on the surface of human monocytoid leukemia cells in vitro

scientific article

Plasma Escherichia coli beta-galactosidase as a marker of tumor burden and response to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cells

scientific article published on 01 May 2000

Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

scientific article published on 01 May 1999

Plasminogen activation at the cell surface-matrix interface.

scientific article published on December 1990

Plasminogen activation in human leukemia and in normal hematopoietic cells.

scientific article

Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin)

scientific article published on 01 June 1987

Production of an active urokinase by leukemia cells: a novel distinction from cell lines of solid tumors

scientific article published on 01 January 1988

Proenzyme to urokinase-type plasminogen activator in human colon cancer: in vitro inhibition by monocyte minactivin after proteolytic activation

scientific article published on 01 February 1987

Proteolytic activity in leg ulcer exudate

scientific article published on 01 February 1993

Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor

scientific article published on March 1990

Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients.

scientific article published in May 2005

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer

scientific article published on May 1999

Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator

scientific article published on 01 October 1981

Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol.

scientific article published on April 2004

Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1

scientific article published on 01 January 1992

Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI-1 and serum CEA.

scientific article published on September 2002

Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis

scientific article published on August 1999

Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases

scientific article published in September 2001

Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.

scientific article published on September 1999

Stimulation of cell surface plasminogen activation by heparin and related polyionic substances

scientific article published on July 1991

Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w/o emulsions incorporating aprotinin

scientific article published in March 2001

Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF-2 domain of blood coagulation factor VII.

scientific article

Tc-radiolabeled composites enabling in vivo imaging of arterial dispersal and retention of microspheres in the vascular network of rabbit lungs, liver, and liver tumors

article

The accumulation of circulating histones on heparan sulphate in the capillary glycocalyx of the lungs

scientific article published on 25 April 2013

The characterisation and function of the polysaccharidases of human synovial fluid in rheumatoid and osteoarthritis ⬇️

scientific article published on July 1975

The complex between urokinase plasminogen activator and its type-1 inhibitor in breast cancer extracts quantitated by ELISA

scientific article published on 01 April 1997

The inhibition of synovial-fluid glycosidases in the rheumatoid joint by metallothiomalates

scientific article published on 01 January 1976

The pathogenesis of osteoarthrosis

scientific article published on July 1979

The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class PAI-2 inhibitor (minactivin)

scientific article published on 01 June 1987

The uptake of soluble and nanoparticulate imaging isotope in model liver tumours after intra-venous and intra-arterial administration

scientific article published on 20 November 2014

The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer

scientific article

The urokinase plasminogen activator system as a target for prognostic studies in breast cancer

scientific article

Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions

scientific article published on 01 December 1994

Tissue-type plasminogen activator in subretinal fluid

scientific article

Urokinase binding to laminin-nidogen. Structural requirements and interactions with heparin

scientific article published on 01 August 1992

Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction

scientific article published on 12 July 2002

Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme

scientific article published on 01 October 1988

Paulina is supported by:

About Paulina

Help